Financials
Financial year 2025
STUDIO PHARMA from Aalter, company number BE0883309219, closed financial year 2025 with a result of € 349,051 after tax. For that financial year STUDIO PHARMA recorded a gross margin of € 852,996 and equity of € 138,700. Compared with financial year 2024, the result moved from € 694,614 to € 349,051. The company is profitable. The buffer shrank hard: equity is 83 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 22, 2026.
€ 138,700
▼ 83% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 349,051
▼ 50% vs 2024
Profit after tax over the fiscal year.
€ 103,388
▼ 30% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 1 million paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
4.9
▼ 0.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 384,337
▲ 4% vs 2024
€ 78,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 30,301
▼ 28% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 45,149
▲ 56% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 69,405
▲ 63% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 783,266 | € 917,872 | € 1,082,559 | € 852,996 | ▼ 21% |
| Profit after taxes | € 307,508 | € 378,479 | € 694,614 | € 349,051 | ▼ 50% |
| Equity | € 1,001,485 | € 1,299,183 | € 814,971 | € 138,700 | ▼ 83% |
| Total debts | € 487,435 | € 453,974 | € 103,845 | € 1,144,330 | ▲ € 1 million |
| Cash | € 214,951 | € 109,011 | € 146,676 | € 103,388 | ▼ 30% |
| Land & buildings | € 394,777 | € 378,532 | € 0 | - | |
| Retained profit | € 989,085 | € 1,286,783 | € 802,571 | € 126,300 | ▼ 84% |
| Dividend | € 90,255 | € 49,958 | € 1,160,483 | € 1,025,322 | ▼ 12% |
| Bank debt | € 340,299 | € 315,087 | € 0 | € 0 | |
| Balance sheet total | € 1,488,920 | € 1,753,158 | € 918,815 | € 1,283,030 | ▲ 40% |
| Employees (FTE) | - | - | 5 | 4.9 | ▼ 0.1 |
Key figures of STUDIO PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to STUDIO PHARMA?
What happened at STUDIO PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 349,051 (▼ 50% vs 2024). Source: NBB ↗
- Ter Loonst BV became a director. NBB
- Patrick Van Dooren became a director. NBB
- Jeremy Dielen became a director. NBB
- Emmanuel Vanderhaegen became a director. NBB
- New establishment in Gent. KBO
- New establishment in Aalter. KBO
- Start of the company according to the CBE. KBO
In short
From € 307,508 profit in 2022 to € 349,051 profit in 2025.
Paid € 632,627 in corporate taxes since 2022.
Best year ever: 2024, with € 694,614 profit.
On average € 174,100 of value added per employee in 2025.
Management
The stake of PHC Group comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
STUDIO PHARMABehind STUDIO PHARMA are Patrick Van Dooren, Ter Loonst BV, Jeremy Dielen and Emmanuel Vanderhaegen. The shares are held by PHC Group (100%).
Directors
According to the 2025 annual accounts
since 2026
Persoon belast met dagelijks bestuur · represented by Caroline Steensels
Also active at: Arphius, C&N HOLDING, KDT Consulting, IN2PHARMA
since 2026
since 2026
since 2026
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Artemeersstraat 11
9880 Aalter
Kerkstraat 108
9050 Gent
Active since 18 November 2021
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0883.309.219
- VAT number
- BE 0883.309.219
- Registered office
- Artemeersstraat 11, 9880 Aalter
- Names & denominations
- STUDIO PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 5 September 2006
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsvoering en beheer
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Activiteiten van adviesbureaus op het gebied van public relations en communicatie
Public relationsbureaus
Adviesbureaus op het gebied van public relations en communicatie